Showing results (71-80 of 177) with videos related to
Sort By:
Pageof 18
Pituitary|January 6, 2001
Long-acting octreotide LAR compared with lanreotide SR in the treatment of acromegalyP Kendall-Taylor, M Miller, J Gebbie, et al.Clinical Endocrinology|August 1, 1989
Urinary excretion of human epidermal growth factor in the various stages of diabetic nephropathyS Dagogo-Jack, S M Marshall, P Kendall-Taylor, et al.Postgraduate Medical Journal|August 1, 1985
Myxoedema followed by TSAb-induced hyperthyroidism: report of 2 casesN R Steel, J P Bingle, I D Ramsay, et al.British Medical Journal (Clinical Research Ed.)|May 26, 1984
Blocking activity to action of thyroid stimulating hormone in serum from patients with primary hypothyroidismN R Steel, D R Weightman, J J Taylor, et al.Diabetic Medicine : a Journal of the British Diabetic Association|July 1, 1991
Carbohydrate tolerance and serum lipids in acromegaly before and during treatment with high dose octreotideR A James, N Møller, S Chatterjee, et al.The Journal of Endocrinology|September 1, 1988
Long-term effects of a gonadotrophin-releasing hormone agonist ([D-Ser(But)6]GnRH(1-9)nonapeptide-ethylamide) on gonadotrophin secretion from human pituitary gonadotroph cell adenomas in vitroM Daniels, P Newland, J Dunn, et al.Clinical Endocrinology|October 1, 1984
Differential TSH and PRL responses to dopamine receptor blockade in acromegalyR W Prescott, D R Weightman, P Kendall-Taylor, et al.Diabetes Research and Clinical Practice|May 23, 1998
Factors influencing preference of insulin regimen in people with type 1 (insulin-dependent) diabetesP Perros, I J Deary, B M FrierHealth Bulletin|June 20, 2003
Do diabetes guidelines influence the content of referral letters by general practitioners to a diabetes specialist clinic?J M Idiculla, P Perros, B M FrierClinical Endocrinology|May 1, 1992
Gonadotrophin secretion in vitro by cells of a pituitary tumour from a patient with multiple endocrine neoplasia type IM Daniels, P Newland, J H Dewar, et al.Pageof 18